In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...
Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel. Improved outcomes were seen with magrolimab plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback